Allegheny Health Network researchers are trying to find out how a drug created for people with a breathing disease can help those with Type 2 diabetes.
“Type 2 diabetes is a consequence of taking in too much energy and not distributing enough,” said Nick Gianoukakis, associate professor for biological sciences and immunology at AHN. “As we eat, we store energy. That becomes fat, and fat is a condition that results in the body’s immune system being sensitized and becoming active. So we create a state of inflammation inside our bodies.”